DPP4 and COVID-19: Inhibition of dipeptidyl peptidase 4 (DPP4) could suppress T-cell proliferation and IL-6 and IL-10 secretion, which regulate the immune response to COVID-19 and reduce inflammation (Iacobellis, 2020), which has been shown to provide cardiovascular and cognitive benefits to the population.